Skip to main content

Advertisement

ADVERTISEMENT

News

Dermacyte - Merakris Therapeutics 

https://www.globenewswire.com/en/news-release/2024/09/05/2941159/0/en/Merakris-Therapeutics-Announces-FDA-Clearance-for-Part-2-of-its-Phase-II-Multicenter-Investigational-New-Drug-Study-of-Dermacyte-Liquid.html

Merakris announced the FDA has granted clearance to commence Part 2 of its Phase II clinical trial for an investigational new drug study of Dermacyte Liquid. The study will begin in late 2024 in up to 10 clinical sites.

Advertisement

Advertisement

Advertisement